Background and Aims Activation of the antitumor immune response using programmed
death receptor‐1 (PD‐1) blockade showed benefit only in a fraction of patients with …

Introduction The prevalence of hepatitis B virus (HBV) infection in Australia is nearly 1%. In
certain well defined groups the prevalence is far greater, yet an estimated 27% of people …

Chronic hepatitis B (CHB) disproportionately affects migrants with low health literacy and
help-seeking behaviour living in high-income countries. Evidence of effective interventions …

Background and Aims Chronic hepatitis B (CHB) is a significant global health concern, and
the most prevalent blood‐borne virus in Australia. World Health Organization (WHO) …

The United States Preventive Services Task Force recently issued new guidance that all
adults aged 18–79 years should be offered screening for hepatitis C virus infection, 1 …

Objectives To assess the impact on diagnosis targets, cost, and cost‐effectiveness of
universal hepatitis B screening in Australia. Design Markov model simulation of disease and …

Background Primary care services are recognised in consecutive national hepatitis B
strategies as priority settings for clinically managing hepatitis B. In 2015, authorised general …

Abstract Background In Australia, only 22% of people with chronic hepatitis B (CHB) are
clinically managed; and a national effort is engaging primary care workforce in providing …

If Australia is to successfully eliminate hepatitis B as a public health threat, it will need to
enhance the chronic hepatitis B (CHB) care cascade. This study used a Markov model to …

Background: Characterisation of hepatitis B virus (HBV) care cascade and decompensated
cirrhosis (DC), hepatocellular carcinoma (HCC), and liver mortality trends are crucial for …